Moreover, the prognostic value of TMED9 was also verified by GEPIA, and results showed that the OS of HCC patients was adversely affected by a higher TMED9 expression level (p = 0.00084) (Fig. 3d). This evidence concerns the gene TMED9 and hepatocellular carcinoma.